✦ LIBER ✦

FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy

✍ Scribed by Tomoki Naoe; Hitoshi Kiyoi; Yukiya Yamamoto; Yosuke Minami; Kazuhito Yamamoto; Ryuzo Ueda; Hidehiko Saito

Publisher: Springer
Year: 2001
Tongue: English
Weight: 101 KB
Volume: 48
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800100301

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ror1, a cell surface receptor tyrosine k

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy

✍ Amir H. DaneshManesh; Eva Mikaelsson; Mahmood Jeddi-Tehrani; Ali Ahmad Bayat; Ro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 205 KB

## Abstract Gene profiling studies of patients with chronic lymphocytic leukemia (CLL) has revealed increased expression of Ror1, a cell surface receptor tyrosine kinase. The aim of present study was to analyze gene and protein expression of Ror1 in CLL cells and normal blood leukocytes. Gene expre

Reactivating PP2A by FTY720 as a Novel t

Reactivating PP2A by FTY720 as a Novel therapy for AML with C-KIT tyrosine kinase domain mutation

✍ Yan Yang; Qing Huang; Yanjun Lu; Xiaoqing Li; Shiang Huang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

## Abstract The tyrosine kinase domain (TKD) mutations of receptor tyrosine kinase C‐KIT are associated with a poor prognosis in acute myeloid leukemia (AML). However, the underlying mechanisms are not fully understood. We found the activity of protein phosphatase 2A (PP2A), a human tumor suppresso